Inhibition of HDAC6 expression decreases brain injury induced by APOE4 and Aβ co‑aggregation in rats

  • Authors:
    • Yuexia Ding
    • Airong Kang
    • Qiling Tang
    • Ying Zhao
  • View Affiliations

  • Published online on: August 8, 2019     https://doi.org/10.3892/mmr.2019.10571
  • Pages: 3363-3370
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The present study aimed to explore the effects of histone deacetylase 6 (HDAC6) on brain injury in rats induced by apolipoprotein E4 (APOE4) and amyloid β protein alloform 1‑40 (Aβ1‑40) copolymerization. The rats were randomly divided into four groups: Control group, sham group, APOE4 + Aβ1‑40 co‑injection group (model group) and HDAC6 inhibitor group (HDAC6 group). The brain injury model was established by co‑injection of APOE4 + Aβ1‑40. Morris water maze experiment was used to observe the spatial memory and learning the ability of rats. Histological changes of the hippocampus were observed by hematoxylin and eosin staining. The mRNA expression levels of choline acetyltransferase (ChAT) and HDAC6 were detected by reverse transcription‑quantitative PCR. Immunohistochemistry was used to detect the protein expression of HDAC6. Western blotting was used to detect the protein expression levels of HDAC6, microtubule‑associated protein tau and glycogen synthase kinase 3β (GSK3β). APOE4 and Aβ1‑40 co‑aggregation decreased the short‑term spatial memory and learning ability of rats, whereas inhibition of HDAC6 activity attenuated the injury. Inhibition of HDAC6 activity resulted in an attenuation of the APOE4 and Aβ1‑40 co‑aggregation‑induced increase in the number of dysplastic hippocampal cells. Further experiments demonstrated that APOE4 and Aβ1‑40 co‑aggregation decreased the expression levels of ChAT mRNA, and the phosphorylation levels of tau GSK3β protein in the hippocampus, whereas inhibition of HDAC6 activity resulted in increased expression of ChAT mRNA, tau protein and GSK3β phosphorylation. The inhibition of HDAC6 activity was also demonstrated to reduce brain injury induced by APOE4 and Aβ1‑40 co‑aggregation in model rats.

References

1 

Alzheimer's Disease International, . Dementia statistics. 2013.

2 

Selkoe DJ and Hardy J: The amyloid hypothesis of Alzheimer's disease at 25 years. EMBO Mol Med. 8:595–608. 2016. View Article : Google Scholar : PubMed/NCBI

3 

Sala Frigerio C and De Strooper B: Alzheimer's disease mechanisms and emerging roads to novel therapeutics. Annu Rev Neurosci. 39:57–79. 2016. View Article : Google Scholar : PubMed/NCBI

4 

Yamin G, Ono K, Inayathullah M and Teplow DB: Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease. Curr Pharm Des. 14:3231–3246. 2008. View Article : Google Scholar : PubMed/NCBI

5 

Marin MA, Ziburkus J, Jankowsky J and Rasband MN: Amyloid-β plaques disrupt axon initial segments. Exp Neurol. 281:93–98. 2016. View Article : Google Scholar : PubMed/NCBI

6 

Thangavel R, Bhagavan SM, Ramaswamy SB, Surpur S, Govindarajan R, Kempuraj D, Zaheer S, Raikwar S, Ahmed ME, Selvakumar GP, et al: Co-expression of glia maturation factor and apolipoprotein E4 in Alzheimer's disease brain. J Alzheimers Dis. 61:553–560. 2018. View Article : Google Scholar : PubMed/NCBI

7 

Qiu Z, Crutcher KA, Hyman BT and Rebeck GW: ApoE isoforms affect neuronal N-methyl-D-aspartate calcium responses and toxicity via receptor-mediated processes. Neuroscience. 122:291–303. 2003. View Article : Google Scholar : PubMed/NCBI

8 

Bour A, Grootendorst J, Vogel E, Kelche C, Dodart JC, Bales K, Moreau PH, Sullivan PM and Mathis C: Middle-aged human apoE4 targeted-replacement mice show retention deficits on a wide range of spatial memory tasks. Behav Brain Res. 193:174–182. 2008. View Article : Google Scholar : PubMed/NCBI

9 

Yin JX, Turner GH, Lin HJ, Coons SW and Shi J: Deficits in spatial learning and memory is associated with hippocampal volume loss in aged apolipoprotein E4 mice. J Alzheimers Dis. 27:89–98. 2011. View Article : Google Scholar : PubMed/NCBI

10 

Chen Y, Durakoglugil MS, Xian X and Herz J: ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling. Proc Natl Acad Sci USA. 107:12011–12016. 2010. View Article : Google Scholar : PubMed/NCBI

11 

van Bergen JM, Li X, Hua J, Schreiner SJ, Steininger SC, Quevenco FC, Wyss M, Gietl AF, Treyer V, Leh SE, et al: Colocalization of cerebral iron with amyloid beta in mild cognitive impairment. Sci Rep. 6:355142016. View Article : Google Scholar : PubMed/NCBI

12 

LaFerla FM, Green KN and Oddo S: Intracellular amyloid-beta in Alzheimer's disease. Nat Rev Neurosci. 8:499–509. 2007. View Article : Google Scholar : PubMed/NCBI

13 

Kuhlmann N, Wroblowski S, Knyphausen P, de Boor S, Brenig J, Zienert AY, Meyer-Teschendorf K, Praefcke GJ, Nolte H, Krüger M, et al: Structural and mechanistic insights into the regulation of the fundamental Rho regulator RhoGDIα by lysine acetylation. J Biol Chem. 291:5484–5499. 2016. View Article : Google Scholar : PubMed/NCBI

14 

Fukada M, Hanai A, Nakayama A, Suzuki T, Miyata N, Rodriguiz RM, Wetsel WC, Yao TP and Kawaguchi Y: Loss of deacetylation activity of Hdac6 affects emotional behavior in mice. PLoS One. 7:e309242012. View Article : Google Scholar : PubMed/NCBI

15 

Chen S, Owens GC, Makarenkova H and Edelman DB: HDAC6 regulates mitochondrial transport in hippocampal neurons. PLoS One. 5:e108482010. View Article : Google Scholar : PubMed/NCBI

16 

Choi H, Kim HJ, Kin J, Kim S, Yang J, Lee W, Park Y, Hyeon SJ, Lee DA, Ryu H, et al: Increased acetylation of Peroxiredoxin1 by HDAC6 inhibition leads to recovery of Aβ-induced impaired axonal transport. Mol Neurodegener. 12:232017. View Article : Google Scholar : PubMed/NCBI

17 

Odagiri S, Tanji K, Mori F, Miki Y, Kakita A, Takahashi H and Wakabayashi K: Brain expression level and activity of HDAC6 protein in neurodegenerative dementia. Biochem Biophys Res Commun. 430:394–399. 2013. View Article : Google Scholar : PubMed/NCBI

18 

Zhang L, Sheng S and Qin C: The role of HDAC6 in Alzheimer's disease. J Alzheimers Dis. 33:283–295. 2013. View Article : Google Scholar : PubMed/NCBI

19 

Majid T, Griffin D, Criss Z, Jarpe M and Pautler RG: Pharmocologic treatment with histone deacetylase 6 inhibitor (ACY-738) recovers Alzheimer's disease phenotype in amyloid precursor protein/presenilin 1 (APP/PS1) mice. Alzheimers Dement (N Y). 1:170–181. 2015.PubMed/NCBI

20 

National Research Council (US) Institute for Laboratory Animal Research, . Guide for the Care and Use of Laboratory AnimalsNational Academies Press; Washington, DC: 1996

21 

Paxinos G and Watson C: The Rat Brain in Stereotaxic Coordinates6th. Hard cover edition. Academic Press; San Diego, CA: 2007

22 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

23 

Jiang S, Nandy P, Wang W, Ma X, Hisa J, Wang C, Wang Z, Niu M, Siedlak S, Torres S, et al: Mfn2 ablation causes an oxidative stress response and eventual neuronal death in the hippocampus and cortex. Mol Neurodegener. 13:52018. View Article : Google Scholar : PubMed/NCBI

24 

Stutzmann GE: The pathogenesis of Alzheimers disease is it a lifelong ‘calciumopathy’? Neuroscientist. 13:546–559. 2007. View Article : Google Scholar : PubMed/NCBI

25 

Neve RL, Harris P, Kosik KS, Kurnit DM and Donlon TA: Identification of cDNA clones for the human microtubule-associated protein, tau, and chromosomal location of the genes for tau and microtubule-associated protein 2. Mol Brain Res. 1:271–280. 1986. View Article : Google Scholar

26 

Alonso A, Zaidi T, Novak M, Grundke Iqbal I and Iqbal K: Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments. Proc Natl Acad Sci USA. 98:6923–6928. 2001. View Article : Google Scholar : PubMed/NCBI

27 

Lasagna-Reeves CA, Castillo-Carranza DL, Guerrero-Muoz MJ, Jackson GR and Kayed R: Preparation and characterization of neurotoxic tau oligomers. Biochemistry. 49:10039–10041. 2010. View Article : Google Scholar : PubMed/NCBI

28 

Ding H, Dolan PJ and Johnson GV: Histone deacetylase 6 interacts with the microtubule-associated protein tau. J Neurochem. 106:2119–2130. 2008. View Article : Google Scholar : PubMed/NCBI

29 

Noack M, Leyk J and Richter-Landsberg C: HDAC6 inhibition results in tau acetylation and modulates tau phosphorylation and degradation in oligodendrocytes. Glia. 62:535–547. 2014. View Article : Google Scholar : PubMed/NCBI

30 

Xiong Y, Zhao K, Wu J, Xu Z, Jin S and Zhang YQ: HDAC6 mutations rescue human tau-induced microtubule defects in Drosophila. Proc Natl Acad Sci USA. 110:4604–4609. 2013. View Article : Google Scholar : PubMed/NCBI

31 

Orta-Salazar E, Cuellar-Lemus CA, Díaz-Cintra S and Feria-Velasco AI: Cholinergic markers in the cortex and hippocampus of some animal species and their correlation to Alzheimer's disease. Neurologia. 29:497–503. 2014.(In English, Spanish). View Article : Google Scholar : PubMed/NCBI

32 

Li Q, Chen M, Liu H, Yang L and Yang G: Expression of APP, BACE1, AChE and ChAT in an AD model in rats and the effect of donepezil hydrochloride treatment. Mol Med Rep. 6:1450–1454. 2012. View Article : Google Scholar : PubMed/NCBI

33 

Espallergues J, Teegarden SL, Veerakumar A, Boulden J, Challis C, Jochems J, Chan M, Petersen T, Deneris E, Matthias P, et al: HDAC6 regulates glucocorticoid receptor signaling in serotonin pathways with critical impact on stress resilience. J Neurosci. 32:4400–4416. 2012. View Article : Google Scholar : PubMed/NCBI

34 

Selenica ML, Benner L, Housley SB, Manchec B, Lee DC, Nash KR, Kalin J, Bergman JA, Kozikowski A, Gordon MN and Morgan D: Histone deacetylase 6 inhibition improves memory and reduces total tau levels in a mouse model of tau deposition. Alzheimers Res Ther. 6:122014. View Article : Google Scholar : PubMed/NCBI

35 

Simões-Pires C, Zwick V, Nurisso A, Schenker E, Carrupt PA and Cuendet M: HDAC6 as a target for neurodegenerative diseases: What makes it different from the other HDACs? Mol Neurodegener. 8:72013. View Article : Google Scholar : PubMed/NCBI

36 

Wu M, He Y, Zhang J, Yang J and Qi J: Co-injection of Aβ1-40 and ApoE4 impaired spatial memory and hippocampal long-term potentiation in rats. Neurosci Lett. 648:47–52. 2017. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

October 2019
Volume 20 Issue 4

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Ding, Y., Kang, A., Tang, Q., & Zhao, Y. (2019). Inhibition of HDAC6 expression decreases brain injury induced by APOE4 and Aβ co‑aggregation in rats. Molecular Medicine Reports, 20, 3363-3370. https://doi.org/10.3892/mmr.2019.10571
MLA
Ding, Y., Kang, A., Tang, Q., Zhao, Y."Inhibition of HDAC6 expression decreases brain injury induced by APOE4 and Aβ co‑aggregation in rats". Molecular Medicine Reports 20.4 (2019): 3363-3370.
Chicago
Ding, Y., Kang, A., Tang, Q., Zhao, Y."Inhibition of HDAC6 expression decreases brain injury induced by APOE4 and Aβ co‑aggregation in rats". Molecular Medicine Reports 20, no. 4 (2019): 3363-3370. https://doi.org/10.3892/mmr.2019.10571